通过Mendelian随机化对可药物基因组进行基因支持的非小细胞肺癌药物重定向标的识别
Yi Feng1,2, Caichen Li1,2, Bo Cheng1,2
1Dpartment of Thoracic Surgery and Oncology, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Translational lung cancer research
|September 12, 2024
概括
这项研究使用孟德尔随机化识别了非小细胞肺癌 (NSCLC) 的七个可用药物的基因. 这些遗传标显示出开发新型NSCLC疗法以提高疗效的前景.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 导致显著的癌症死亡率.
- 向疗法提供了进步,但由于药物向不足而面临限制.
- 新的治疗点对于扩大NSCLC治疗选择至关重要.
研究的目的:
- 在NSCLC中识别可用药物的基因.
- 预测针对NSCLC的向药物的疗效.
- 评估NSCLC候选基因的预后价值.
主要方法:
- 使用双样本的门德尔随机化 (MR) 来评估基因与药物标的关联.
- 进行了敏感性分析,以解决潜在的混因素.
- 用RNA测序数据和卡普兰-梅尔曲线进行验证和预后评估.
主要成果:
- 核磁共振扫描检查发现了七个候选可药性基因.
- 特定的基因 (CD33,ENG,ICOSLG,IL18R1) 与肺腺癌有关.
- 其他基因 (VSIR,FSTL1,TIMP2) 与肺状细胞癌有关.
- 转录基因数据验证了这些发现.
结论:
- 基因支持的药物标在临床试验中更有可能成功.
- 这项研究提供了基因证据来指导NSCLC药物开发.
- 优先考虑这些已识别的基因可以加速开发有效的NSCLC疗法.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K